Topical Pharmaceutical Formulations and Methods of Treatment

John Staniforth (Inventor), Michael J Tobyn (Inventor)

Research output: Patent

Abstract

In certain embodiments, the present invention is directed to a pharmaceutical formulation for topical administration on a mammal, comprising a unit dose of a therapeutically effective amount of a therapeutic agent and a pharmaceutically acceptable carrier medium therefor, said formulation being solid at ambient temperature and having a softening point of not higher than 35 DEG C, such that when the formulation is placed in continuous contact with the skin of a mammalian patient, it is softened to a consistency to effect substantial application of the unit dose of said therapeutic agent onto a desired skin area of the mammalian patient within a time period of less than 10 minutes.
Original languageEnglish
Patent numberPL360868 (A1)
IPCA61J3/00
Publication statusPublished - 20 Sep 2004

Fingerprint

Drug Compounding
Topical Administration
Skin
Mammals
Temperature
Therapeutics

Cite this

Staniforth, J., & Tobyn, M. J. (2004). IPC No. A61J3/00. Topical Pharmaceutical Formulations and Methods of Treatment. (Patent No. PL360868 (A1)).

Topical Pharmaceutical Formulations and Methods of Treatment. / Staniforth, John (Inventor); Tobyn, Michael J (Inventor).

IPC No.: A61J3/00. Patent No.: PL360868 (A1).

Research output: Patent

Staniforth, J & Tobyn, MJ 2004, Topical Pharmaceutical Formulations and Methods of Treatment, Patent No. PL360868 (A1), IPC No. A61J3/00.
Staniforth J, Tobyn MJ, inventors. Topical Pharmaceutical Formulations and Methods of Treatment. A61J3/00. 2004 Sep 20.
Staniforth, John (Inventor) ; Tobyn, Michael J (Inventor). / Topical Pharmaceutical Formulations and Methods of Treatment. IPC No.: A61J3/00. Patent No.: PL360868 (A1).
@misc{768c6ea8b9b04b499c40bc081da9e979,
title = "Topical Pharmaceutical Formulations and Methods of Treatment",
abstract = "In certain embodiments, the present invention is directed to a pharmaceutical formulation for topical administration on a mammal, comprising a unit dose of a therapeutically effective amount of a therapeutic agent and a pharmaceutically acceptable carrier medium therefor, said formulation being solid at ambient temperature and having a softening point of not higher than 35 DEG C, such that when the formulation is placed in continuous contact with the skin of a mammalian patient, it is softened to a consistency to effect substantial application of the unit dose of said therapeutic agent onto a desired skin area of the mammalian patient within a time period of less than 10 minutes.",
author = "John Staniforth and Tobyn, {Michael J}",
year = "2004",
month = "9",
day = "20",
language = "English",
type = "Patent",
note = "PL360868 (A1); A61J3/00",

}

TY - PAT

T1 - Topical Pharmaceutical Formulations and Methods of Treatment

AU - Staniforth, John

AU - Tobyn, Michael J

PY - 2004/9/20

Y1 - 2004/9/20

N2 - In certain embodiments, the present invention is directed to a pharmaceutical formulation for topical administration on a mammal, comprising a unit dose of a therapeutically effective amount of a therapeutic agent and a pharmaceutically acceptable carrier medium therefor, said formulation being solid at ambient temperature and having a softening point of not higher than 35 DEG C, such that when the formulation is placed in continuous contact with the skin of a mammalian patient, it is softened to a consistency to effect substantial application of the unit dose of said therapeutic agent onto a desired skin area of the mammalian patient within a time period of less than 10 minutes.

AB - In certain embodiments, the present invention is directed to a pharmaceutical formulation for topical administration on a mammal, comprising a unit dose of a therapeutically effective amount of a therapeutic agent and a pharmaceutically acceptable carrier medium therefor, said formulation being solid at ambient temperature and having a softening point of not higher than 35 DEG C, such that when the formulation is placed in continuous contact with the skin of a mammalian patient, it is softened to a consistency to effect substantial application of the unit dose of said therapeutic agent onto a desired skin area of the mammalian patient within a time period of less than 10 minutes.

M3 - Patent

M1 - PL360868 (A1)

ER -